Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TSX VENTURE EXCHANGE  >  DIAGNOS Inc.    ADK   CA2524423068

DIAGNOS INC.

(ADK)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

DIAGNOS : Announces the Resumption of Screening Operations in Saudi Arabia and Conveys Congratulations to Dr. Salman Abdullah Al-Mutairi

11/13/2020 | 09:18am EST

BROSSARD - Diagnos Inc. ('DIAGNOS' or 'the Corporation') (TSX Venture: ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), is pleased to announce the reopening of the screening clinic in Hafar al-Batin, a region that includes over 150,000 diabetics for a total population of over 600,000 people.

Al Kanhoor Medical, Diagnos and its employees also wish to offer their sincerest congratulations to the Secretary General of the Health Care Association, Dr. Salman Abdullah Al-Mutairi, for his assignment as Secretary General of the Council of Private Associations in the Kingdom. We would also like to note the great efforts made by Dr. Salman and the Enaya Association, led by Dr. Abdul Rahman Al-Suwailem, in the retinal examination project for diabetics in many regions of the Kingdom.

About DIAGNOS

DIAGNOS is a publicly-traded Canadian corporation with a mission of early detection of critical health issues through the use of its Artificial Intelligence ('AI') tool CARA (Computer Assisted Retina Analysis) to assist doctors, nurses and specialist in their daily work with diabetics. CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care. CARA's Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible. CARA is a cost-effective tool for screening large numbers of patients in real-time. CARA complies with local regulations, is FDA cleared for commercialization in the United States of America, is Health Canada licensed for commercialization in Canada, licensed by the Saudi FDA, COFEPRIS in Mexico and is CE marking compliant in Europe.

About Kanhoor Medical Co

Al Kanhoor is focused on selling telemedicine and AI assisted application in KSA. Al Kanhoor is providing technology for remote patient observation and marketing Diagnos suit of products in KSA and beyond. Al Kanhoor is a sister company of HAJZTELECOM 'HTC' Technology & Telecom solutions provider and contractor to Saudi Telecom - STC- contractor since 1997.

This news release contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. DIAGNOS disclaims any intention or obligation to publically update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.

Contact:

Mr. Andre Larente

Tel: 450-678-8882

(C) 2020 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
DIAGNOS INC. 0.00% 0.65 Delayed Quote.10.17%
SAUDI TELECOM COMPANY -0.18% 111.4 End-of-day quote.5.09%
All news about DIAGNOS INC.
01/21DIAGNOS : 2021-01-21, DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit &nd..
PU
01/21DIAGNOS : 2021-01-19, DIAGNOS announces a 3-year partnership agreement with the ..
PU
01/21DIAGNOS : 2021-01-05, DIAGNOS Provides Market Activity Update – Download P..
PU
01/21DIAGNOS : Successfully Completes ISO 13485 / MDSAP Audit
AQ
01/20DIAGNOS : announces a 3-year partnership agreement with the University of Montre..
AQ
01/19DIAGNOS : announces a 3-year partnership agreement with the University of Montre..
AQ
01/14Diagnos Announces Partnership With Saudi Arabia's Magrabi Hospitals to Screen..
MT
01/14DIAGNOS : Announces Partnership in Saudi Arabia with Magrabi Hospitals and Cente..
AQ
01/05Diagnos Says No Undisclosed Material Information Behind 7% Rise in Shares
MT
01/05DIAGNOS : Provides Market Activity Update
AQ
More news
Financials
Sales 2020 0,33 M 0,26 M 0,26 M
Net income 2020 -3,38 M -2,65 M -2,65 M
Net cash 2020 1,51 M 1,18 M 1,18 M
P/E ratio 2020 -2,35x
Yield 2020 -
Capitalization 42,7 M 33,5 M 33,5 M
EV / Sales 2019 34,5x
EV / Sales 2020 31,6x
Nbr of Employees 22
Free-Float 64,4%
Chart DIAGNOS INC.
Duration : Period :
DIAGNOS Inc. Technical Analysis Chart | ADK | CA2524423068 | MarketScreener
Income Statement Evolution
Managers and Directors
NameTitle
André M. Larente President, Chief Executive Officer & Director
François Côté Chairman
Marc-André Massue Chief Financial Officer, Secretary & VP-Finance
Hadi Chakor Chief Medical Officer
Reid Maclellan Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DIAGNOS INC.10.17%34
MICROSOFT CORPORATION1.15%1 708 294
SEA LIMITED18.81%120 888
ZOOM VIDEO COMMUNICATIONS, INC.13.66%111 910
ATLASSIAN CORPORATION PLC0.68%58 675
DASSAULT SYSTÈMES SE-0.69%52 507